Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jinxuan Wu

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
American Journal of Cancer Research|January 13, 2025
Synergistic combination therapy with ONC201 or ONC206, and enzalutamide or darolutamide in preclinical studies of castration-resistant prostate cancerLaura Jinxuan Wu, Maximilian Pinho-Schwermann, Lanlan Zhou, et al.
Cell Reports|March 2, 2025
Temporal dynamics of immune cell transcriptomics in brain metastasis progression influenced by gut microbiome dysbiosisSamantha M Golomb, Ian H Guldner, Emilija Aleksandrovic, et al.
Materials Today. Bio|October 27, 2025
Anaerobic bio-reduction ignites persistent photothermal conversion in misaligned porphyrin supramolecular assembly for infected wound regenerationXuejiao Wang, Qiyang Cai, Yingjie Dai, et al.
Oncotarget|March 27, 2025
Imipridones ONC201/ONC206 + RT/TMZ triple (IRT) therapy reduces intracranial tumor burden, prolongs survival in orthotopic IDH-WT GBM mouse model, and suppresses MGMTLanlan Zhou, Leiqing Zhang, Jun Zhang, et al.
The Journal of Biological Chemistry|September 18, 2025
Inhibition of HDAC7 reprograms the histone H3.3 landscape to induce heterochromatin spreading and DNA replication defects in cancer cellsOla Hassan, Mattia Pizzagalli, Owen P Leary, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
American Journal of Cancer Research|January 13, 2025
Synergistic combination therapy with ONC201 or ONC206, and enzalutamide or darolutamide in preclinical studies of castration-resistant prostate cancerLaura Jinxuan Wu, Maximilian Pinho-Schwermann, Lanlan Zhou, et al.
Cell Reports|March 2, 2025
Temporal dynamics of immune cell transcriptomics in brain metastasis progression influenced by gut microbiome dysbiosisSamantha M Golomb, Ian H Guldner, Emilija Aleksandrovic, et al.
Materials Today. Bio|October 27, 2025
Anaerobic bio-reduction ignites persistent photothermal conversion in misaligned porphyrin supramolecular assembly for infected wound regenerationXuejiao Wang, Qiyang Cai, Yingjie Dai, et al.
Oncotarget|March 27, 2025
Imipridones ONC201/ONC206 + RT/TMZ triple (IRT) therapy reduces intracranial tumor burden, prolongs survival in orthotopic IDH-WT GBM mouse model, and suppresses MGMTLanlan Zhou, Leiqing Zhang, Jun Zhang, et al.
The Journal of Biological Chemistry|September 18, 2025
Inhibition of HDAC7 reprograms the histone H3.3 landscape to induce heterochromatin spreading and DNA replication defects in cancer cellsOla Hassan, Mattia Pizzagalli, Owen P Leary, et al.
Pageof 2